Drug Discov Ther. 2019;13(1):59-61. (DOI: 10.5582/ddt.2019.01001)
Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
Naveen T, Biswas A, Wig N, Soneja M, Jorwal P, Durga CS, Singla P, Chaudhary C, Baitha U
Familial hypercholesterolemia (FH) is a form of primary hyperlipoproteinemia characterized by the presence of high concentrations of serum low density lipoprotein (LDL) cholesterol, increased tendency to form xanthomas and early onset of coronary artery disease. This disease is an autosomal dominant disorder caused by defects in the gene that encode for the LDL receptor. Homozygous familial hypercholesterolemia is a rare occurrence and here we report a case of an 18-year-old girl with familial hypercholesterolemia treated with antilipidemic drugs and controlled only with LDL apheresis. The patient expired after 3 months highlighting the difficulties in management due to economic constraints in a resource limited setting in spite of availability of effective therapy.